Acute kidney tubular necrosis
MONDO:0006637Acute renal failure caused by the cell death of the renal tubules. Causes include nephrotoxins, cytotoxic drugs, and antibiotics.
Also known as: acute renal failure with lesion of tubular necrosis, acute renal failure with tubular necrosis, acute tubular necrosis
17 clinical trials for this condition and its sub-types, 2 tagged with Acute kidney tubular necrosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New dialysis device for kids: a safer way to clean blood?
Disease control Recruiting nowThis study tests a special dialysis machine, the MultiFiltratePRO, in children with acute kidney failure. The goal is to see if it can deliver at least 80% of the prescribed treatment within 72 hours while being safe. About 43 children weighing between 8 and 40 kilograms will be …
Sponsor: Fresenius Medical Care Deutschland GmbH • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Gentle suction on kidneys during heart surgery may prevent damage
Disease control Recruiting nowThis trial tests a device called JuxtaFlow that applies mild suction to the kidneys during heart surgery. The goal is to see if it can protect kidney function in people with pre-existing kidney problems. 124 adults undergoing heart surgery with a heart-lung machine will be random…
Sponsor: 3ive Labs • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Kidney patients needed for Early-Stage drug safety study
Knowledge-focused Recruiting nowThis study tests a single dose of hydroxynidone capsules in 56 people with different levels of kidney function and healthy volunteers. The goal is to see how the drug moves through the body and if it is safe in people with kidney problems. Participants will have blood and urine t…
Phase 1 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New cholesterol drug tested in kidney patients
Knowledge-focused Recruiting nowThis study looks at how a new cholesterol-lowering tablet, HRS-1301, behaves in people with mild, moderate, or severe kidney problems compared to healthy volunteers. The goal is to understand if kidney function changes how the drug works, so doctors can give the right dose. About…
Phase 1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC